These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 973989)

  • 21. The action of halofenate on platelet shape change and prostaglandin synthesis.
    Favis GR; Colman RW
    J Lab Clin Med; 1978 Jul; 92(1):45-52. PubMed ID: 659964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acetylsalicylic acid and prostaglandin on endotoxin-induced pulmonary platelet sequestration.
    Thörnee LJ; Kuenzig M; Thörne LJ
    Acta Chir Scand; 1981; 147(3):161-2. PubMed ID: 7199241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
    Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.
    Sinzinger H; O'Grady J; Fitscha P; Kaliman J
    N Engl J Med; 1984 Oct; 311(16):1052. PubMed ID: 6384781
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.
    Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
    Br J Pharmacol; 1975 Jan; 53(1):121-5. PubMed ID: 1125484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
    Boullin DJ; Glenton PA
    Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.
    Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
    Br J Clin Pharmacol; 1975 Feb; 2(1):37-9. PubMed ID: 791317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet aggregation and release in a forming immune complex system.
    Clark WF; Reid BD; Dennis BN; Burka JF
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):687-93. PubMed ID: 6777899
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
    Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
    N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation induced by antilymphocyte serum. I. Differences between washed and unwashed platelets.
    Hussey CV; Wang TY; Garancis JC; Fobian JE
    Am J Clin Pathol; 1975 Nov; 64(5):580-90. PubMed ID: 811109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostaglandins and platelet function].
    Carreras Vescio LO
    Sangre (Barc); 1979; 24(3):303-19. PubMed ID: 382403
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs.
    Blois SL; Allen DG; Wood RD; Conlon PD
    Am J Vet Res; 2010 Mar; 71(3):349-58. PubMed ID: 20187838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.